CPRT vs ROL vs RBA
161 measures in 16 categories, one definition each, computed from filings and market data.
CPRT66.2
Copart, Inc.
Industrials · Specialty Business Services
$27.87 +0.43%$25.8B mkt cap
Score DNA
ROL65.7
Rollins, Inc.
Industrials · Specialty Business Services
$33.45 −1.30%$16.1B mkt cap
Score DNA
RBA57.3
RB Global, Inc.
Industrials · Specialty Business Services
$84.30 −3.21%$15.6B mkt cap
Score DNA
Price, rebased to 100 three years ago
CPRT ROL RBA · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 4 |
| Insider $ bought, 180d | — | — | $0.18M |
| Congress purchases, 180d | 1 | 2 | 0 |
| Last Congress purchase | 2026-09-25 | 2026-09-25 | — |
| 13F net change in holders | −18 | −7 | +20 |
| ETFs adding shares, 30d | 1,011 | 970 | 82 |
| ETFs trimming, 30d | 949 | 738 | 75 |
| Net ETF funds, 30d | +62 | +232 | +7 |
Valuation
16 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| P/E (TTM) | 17.4x
24th
|
30.3x
64th
|
32.2x
68th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 2.58
64th
|
2.61
73rd
|
0.67
45th
|
| Price / sales | 5.5x
86th
|
4.1x
76th
|
3.2x
66th
|
| Price / book | 2.8x
58th
|
11.3x
92nd
|
2.6x
50th
|
| Price / tangible book | 3.3x
27th
|
— | — |
| Price / free cash flow | 20.4x
65th
|
26.0x
81st
|
23.0x
73rd
|
| Price / operating cash flow | 16.1x
71st
|
24.9x
89th
|
18.0x
79th
|
| Enterprise value | $21.4B
93rd
|
$17.1B
83rd
|
$18.0B
86th
|
| EV / sales | 4.6x
86th
|
4.4x
79th
|
3.7x
72nd
|
| EV / EBITDA | 10.4x
36th
|
19.8x
82nd
|
13.1x
57th
|
| EV / EBIT | 11.7x
27th
|
23.3x
65th
|
22.9x
62nd
|
| EV / free cash flow | 16.9x
46th
|
27.6x
77th
|
26.5x
73rd
|
| Earnings yield | 5.7%
79th
|
3.3%
45th
|
3.1%
41st
|
| FCF yield | 4.9%
41st
|
3.8%
28th
|
4.4%
34th
|
| Operating cash flow yield | 6.2%
31st
|
4.0%
14th
|
5.6%
24th
|
| Graham number (per share) | $18.22
27th
|
$8.59
23rd
|
$43.49
82nd
|
Profitability (TTM)
12 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| Gross margin | 44.7%
62nd
|
51.6%
76th
|
42.1%
55th
|
| EBITDA margin | 44.3%
100th
|
22.0%
66th
|
28.2%
83rd
|
| Operating margin | 35.4%
100th
|
18.7%
79th
|
18.9%
83rd
|
| EBIT margin | 39.3%
100th
|
18.7%
76th
|
16.2%
72nd
|
| Net margin | 31.8%
100th
|
13.6%
76th
|
10.0%
69th
|
| NOPAT margin | 28.6%
100th
|
14.2%
76th
|
15.1%
83rd
|
| FCF margin | 27.2%
89th
|
15.8%
71st
|
14.0%
61st
|
| Operating cash flow margin | 34.4%
89th
|
16.5%
57th
|
17.9%
68th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 9.2%
21st
|
30.4%
72nd
|
17.6%
48th
|
| Stock comp / revenue | 0.8%
45th
|
0.3%
21st
|
1.2%
59th
|
| Effective tax rate | 19.3%
7th
|
23.9%
52nd
|
20.2%
14th
|
Returns on capital
11 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| ROE (on average equity) | 16.2%
77th
|
37.0%
92nd
|
8.1%
38th
|
| ROA | 14.8%
86th
|
16.3%
90th
|
3.9%
45th
|
| ROIC | 28.4%
93rd
|
22.9%
82nd
|
8.7%
57th
|
| ROCE | 19.7%
86th
|
30.3%
93rd
|
7.1%
38th
|
| Return on tangible assets | 18.2%
90th
|
22.4%
93rd
|
6.4%
45th
|
| Cash ROIC (OCF / invested capital) | 34.2%
86th
|
26.6%
71st
|
10.3%
32nd
|
| Gross profitability (GP / assets) | 20.8%
52nd
|
60.3%
90th
|
14.6%
24th
|
| ROIC, 3-yr average | 28.5%
92nd
|
20.9%
84th
|
5.7%
56th
|
| ROIC, 5-yr average | 65.4%
100th
|
24.9%
88th
|
8.2%
62nd
|
| ROE, 5-yr average | 19.1%
79th
|
33.4%
96th
|
9.6%
33rd
|
| Incremental ROIC | -76.9%
19th
|
138.5%
85th
|
-33.8%
30th
|
Growth
17 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| Revenue growth (TTM YoY) | 0.4%
14th
|
9.9%
54th
|
10.1%
57th
|
| Revenue growth (QoQ) | -6.8%
11th
|
19.0%
89th
|
6.7%
61st
|
| Revenue CAGR, 3 yr | 6.4%
48th
|
11.0%
68th
|
25.3%
80th
|
| Revenue CAGR, 5 yr | 11.6%
60th
|
11.3%
56th
|
27.5%
80th
|
| Gross profit CAGR, 3 yr | 6.3%
40th
|
10.9%
56th
|
12.4%
72nd
|
| Operating income CAGR, 3 yr | 3.6%
35th
|
11.3%
60th
|
48.1%
95th
|
| Net income growth (TTM YoY) | -4.4%
20th
|
8.7%
35th
|
16.2%
50th
|
| Net income CAGR, 3 yr | 6.2%
50th
|
10.7%
56th
|
48.9%
89th
|
| EPS growth (TTM YoY) | -2.3%
20th
|
9.4%
30th
|
16.0%
50th
|
| EPS CAGR, 3 yr | 6.7%
50th
|
11.6%
56th
|
47.8%
89th
|
| EPS CAGR, 5 yr | 9.8%
71st
|
10.2%
76th
|
9.6%
65th
|
| FCF growth (TTM YoY) | 3.0%
32nd
|
-2.0%
27th
|
12.2%
36th
|
| FCF CAGR, 3 yr | 14.3%
41st
|
9.6%
18th
|
75.3%
86th
|
| Operating cash flow CAGR, 3 yr | 5.6%
22nd
|
9.0%
26th
|
40.3%
91st
|
| Book value CAGR, 3 yr | 15.5%
83rd
|
2.9%
42nd
|
3.1%
46th
|
| Dividend CAGR, 3 yr | — | 4.1%
60th
|
1.7%
33rd
|
| Sustainable growth rate | 16.2%
82nd
|
13.0%
64th
|
3.6%
14th
|
Margin history & stability
7 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| Gross margin, 3-yr average | 45.0%
62nd
|
52.3%
77th
|
43.6%
50th
|
| Operating margin, 3-yr average | 36.3%
100th
|
19.1%
81st
|
17.6%
77th
|
| Net margin, 3-yr average | 32.5%
100th
|
13.8%
85th
|
9.4%
62nd
|
| FCF margin, 3-yr average | 25.4%
88th
|
16.5%
81st
|
14.1%
65th
|
| Revenue stability (0-1) | 0.94
58th
|
1.00
96th
|
0.93
50th
|
| Earnings stability (0-1) | 0.93
88th
|
0.97
92nd
|
0.71
65th
|
| Margin stability (0-1) | 0.95
73rd
|
0.99
100th
|
0.85
35th
|
Liquidity (latest quarter)
7 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| Cash & short-term investments | $4.5B
100th
|
$109.1M
38th
|
$524.9M
90th
|
| Net cash (− = net debt) | $4.4B
100th
|
−$1.0B
52nd
|
−$2.4B
14th
|
| Working capital | $4.9B
100th
|
−$347.7M
7th
|
$449.6M
76th
|
| Current ratio | 7.91
100th
|
0.63
7th
|
1.31
41st
|
| Quick ratio | 7.84
100th
|
0.58
11th
|
1.22
41st
|
| Cash ratio (cash + ST investments / current liabilities) | 6.38
100th
|
0.12
33rd
|
0.36
59th
|
| Defensive interval (days) | 4,485 days
100th
|
112 days
10th
|
559 days
66th
|
Leverage & solvency (latest quarter)
13 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| Total debt | $88.4M
28th
|
$1.1B
48th
|
$2.9B
90th
|
| Debt / equity | 0.01
4th
|
0.78
58th
|
0.49
46th
|
| Net debt / equity | −0.48
8th
|
0.70
65th
|
0.40
42nd
|
| Debt / assets | 0.9%
7th
|
33.2%
55th
|
23.5%
41st
|
| Debt / capital | 1.0%
4th
|
43.8%
58th
|
32.7%
46th
|
| Debt / EBITDA | 0.04
7th
|
1.29
36th
|
2.14
46th
|
| Net debt / EBITDA | −2.13
11th
|
1.17
43rd
|
1.76
50th
|
| Interest coverage (EBIT / interest) | — | 21.8x
91st
|
4.3x
65th
|
| Cash interest coverage | — | 19.2x
79th
|
4.7x
58th
|
| Debt payback (years of OCF) | 0.1 yrs
11th
|
1.7 yrs
39th
|
3.4 yrs
43rd
|
| Liabilities / assets | 9.1%
3rd
|
57.4%
55th
|
51.5%
52nd
|
| IS credit model rating | AA+ | AA | BBB+ |
| Implied credit spread (bps) | 65
3rd
|
80
21st
|
225
41st
|
Efficiency
11 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| Asset turnover | 0.46
31st
|
1.20
83rd
|
0.39
17th
|
| Fixed asset turnover | 1.22
7th
|
7.34
55th
|
1.55
10th
|
| Inventory turnover | 56.7
93rd
|
44.2
79th
|
26.1
57th
|
| Receivables turnover | 5.9
29th
|
16.7
93rd
|
7.8
64th
|
| Days sales outstanding | 61 days
72nd
|
22 days
10th
|
47 days
38th
|
| Days inventory outstanding | 6 days
7th
|
8 days
21st
|
14 days
43rd
|
| Days payables outstanding | 60 days
86th
|
15 days
7th
|
18 days
18th
|
| Cash conversion cycle (days) | 8 days
32nd
|
15 days
46th
|
42 days
71st
|
| Capex / revenue | 7.2%
79th
|
0.7%
4th
|
3.9%
54th
|
| Capex / depreciation | 1.46
96th
|
0.21
11th
|
0.32
22nd
|
| Operating expense ratio | 9.8%
24th
|
34.2%
76th
|
0.1%
0th
|
Cash flow & earnings quality
7 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| Operating cash flow / net income | 1.08
4th
|
1.22
12th
|
1.79
36th
|
| FCF / net income | 0.85
12th
|
1.16
28th
|
1.40
48th
|
| FCF / operating cash flow | 79.0%
67th
|
95.7%
100th
|
78.2%
63rd
|
| Capex / operating cash flow | 21.0%
33rd
|
4.3%
0th
|
21.8%
37th
|
| Accruals ratio | -1.2%
93rd
|
-3.5%
79th
|
-3.1%
86th
|
| Sloan accruals ratio | -3.2%
69th
|
-6.2%
31st
|
-4.5%
52nd
|
| Earnings quality score (0-1) | 1.00
56th
|
1.00
56th
|
1.00
56th
|
Scores & forensic checks
15 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| IS score | 66
79th
|
66
76th
|
57
59th
|
| IS profitability | 79
93rd
|
74
86th
|
35
55th
|
| IS growth | 37
18th
|
56
46th
|
58
54th
|
| IS value | 56
66th
|
34
24th
|
40
31st
|
| IS momentum | 62
21st
|
80
43rd
|
86
61st
|
| IS risk (safety) | 100
68th
|
100
68th
|
65
46th
|
| IS quality | 84
90th
|
79
79th
|
72
69th
|
| IS balance sheet | 92
100th
|
57
66th
|
54
59th
|
| IS earnings quality | 76
69th
|
85
97th
|
76
72nd
|
| IS cash flow | 77
76th
|
64
45th
|
64
48th
|
| Piotroski F-score (0-9) | 6
28th
|
6
28th
|
7
59th
|
| Altman Z-score | 21.1
100th
|
8.4
86th
|
2.8
57th
|
| Beneish M-score | −2.64
46th
|
−2.57
57th
|
−1.69
93rd
|
| Ohlson O-score | −14.38
0th
|
−7.53
48th
|
−8.05
37th
|
| IS credit score | 91
83rd
|
90
79th
|
61
55th
|
Size (TTM)
8 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| Market cap | $25.8B
93rd
|
$16.1B
90th
|
$15.6B
86th
|
| Revenue | $4.7B
76th
|
$3.9B
72nd
|
$4.9B
79th
|
| EBITDA | $2.1B
90th
|
$862.5M
72nd
|
$1.4B
83rd
|
| Net income | $1.5B
93rd
|
$531.7M
86th
|
$485.3M
79th
|
| Free cash flow | $1.3B
86th
|
$619.2M
79th
|
$679.8M
83rd
|
| Total assets | $10.0B
83rd
|
$3.4B
52nd
|
$12.5B
90th
|
| Shareholders' equity | $9.1B
97th
|
$1.4B
55th
|
$6.0B
93rd
|
| Employees | 21,000
71st
|
21,946
75th
|
8,350
39th
|
Price performance
9 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| 1 day | +0.4% | −1.3% | −3.2% |
| 1 week | +2.0% | +4.6% | −1.8% |
| 1 month | −6.0% | +1.4% | +0.3% |
| 3 months | +1.4% | −24.9% | −23.8% |
| 6 months | −16.7% | −38.7% | −19.1% |
| Year to date | −26.2% | −42.7% | −18.1% |
| 1 year | −37.5% | −39.4% | −19.5% |
| 3 years, cumulative | −39.6% | −4.1% | +29.1% |
| 5 years, cumulative | −20.6% | −2.5% | +44.2% |
Technicals
4 measures| Measure | CPRT | ROL | RBA |
|---|---|---|---|
| RSI 14 | 47.4 | 55.9 | 48.4 |
| From 52-week high | −39.3% | −48.9% | −29.3% |
| From 52-week low | +8.4% | +14.2% | +8.1% |
| Beta | 1.06 | 0.73 | 0.53 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17